Oh, S. T., Mesa, R., Harrison, C., Bose, P., Gerds, A. T., Heaney, M. L., Gupta, V., Scott, B. L., Kiladjian, J.-J., Lucchesi, A., Buckley, S., Tyavanagimatt, S., Roman-Torres, K., Mascarenhas, J., & Verstovsek, S. (2022). Pacritinib Is a Potent ACVR1 Inhibitor with Significant Anemia Benefit in Patients with Myelofibrosis. Blood, 140(Supplement 1), 1518–1521. https://doi.org/10.1182/blood-2022-156936